Fast Market Research

Active Biotech AB - Product Pipeline Review - 2012 - New Market Research Report

New Pharmaceuticals market report from Global Markets Direct: "Active Biotech AB - Product Pipeline Review - 2012"

 
Repost This

Boston, MA -- (SBWIRE) -- 10/27/2012 -- Global Markets Direct's pharmaceuticals report, "Active Biotech AB - Product Pipeline Review - 2012" provides data on the Active Biotech AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Active Biotech AB's corporate website, SEC filings, investor presentations and featured press releases, both from Active Biotech AB and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

View Full Report Details and Table of Contents

- Active Biotech AB - Brief Active Biotech AB overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Active Biotech AB human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Active Biotech AB with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Active Biotech AB's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get this Report

- Evaluate Active Biotech AB's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Active Biotech AB in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Active Biotech AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Active Biotech AB.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Active Biotech AB and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Active Biotech AB - Product Pipeline Review - Q1 2011
- Alligator Bioscience AB - Product Pipeline Review - 2012
- Autoimmune Disorders - Pipeline Review, H2 2012
- Aduro BioTech - Product Pipeline Review - 2012
- Melanoma - Pipeline Review, H2 2012
- Medivir AB - Product Pipeline Review - 2012
- Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2012
- Oncolytics Biotech Inc. - Product Pipeline Review - 2012
- Digna Biotech, S.L. - Product Pipeline Review - 2012
- Sarcomas - Pipeline Review, H1 2012